SAREPTA THERAPEUTICS, INC. Amortization of Intangible Assets
SAREPTA THERAPEUTICS, INC. (SRPT) reported Amortization of Intangible Assets of $717.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $717.00K, a 7.50% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $691.00K, a 14.98% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $677.00K, a 12.65% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $677.00K, a 12.46% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2025 was $2.62M, a 9.02% increase from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2024 was $2.40M, a 54.27% increase from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2023 was $1.56M, a 118.35% increase from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2022 was $714.00K, a 1.13% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $717.00K 10-Q · filed 2026-08-05 | $1.41M 10-Q · filed 2026-08-05 | $2.08M derived: sum of 3 quarters · filed 2026-08-05 | $2.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $691.00K 10-Q · filed 2026-05-06 | $1.37M derived: sum of 2 quarters · filed 2026-05-06 | $2.04M derived: sum of 3 quarters · filed 2026-05-06 | $2.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $677.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.35M derived: sum of 2 quarters · filed 2026-03-02 | $2.02M derived: sum of 3 quarters · filed 2026-08-05 | $2.62M 10-K · filed 2026-03-02 |
| 2025-09-30 | $677.00K 10-Q · filed 2025-11-06 | $1.34M derived: sum of 2 quarters · filed 2026-08-05 | $1.95M 10-Q · filed 2025-11-06 | $2.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $667.00K 10-Q · filed 2026-08-05 | $1.27M 10-Q · filed 2026-08-05 | $1.87M derived: sum of 3 quarters · filed 2026-08-05 | $2.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $601.00K 10-Q · filed 2026-05-06 | $1.20M derived: sum of 2 quarters · filed 2026-05-06 | $1.80M derived: sum of 3 quarters · filed 2026-05-06 | $2.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.20M derived: sum of 2 quarters · filed 2026-03-02 | $1.80M derived: sum of 3 quarters · filed 2026-03-02 | $2.40M 10-K · filed 2026-03-02 |
| 2024-09-30 | $602.00K 10-Q · filed 2025-11-06 | $1.20M derived: sum of 2 quarters · filed 2025-11-06 | $1.80M 10-Q · filed 2025-11-06 | $2.57M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $601.00K 10-Q · filed 2025-08-06 | $1.20M 10-Q · filed 2025-08-06 | $1.97M derived: sum of 3 quarters · filed 2026-03-02 | $2.40M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $601.00K 10-Q · filed 2025-05-06 | $1.36M derived: sum of 2 quarters · filed 2026-03-02 | $1.80M derived: sum of 3 quarters · filed 2026-03-02 | $1.98M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.20M derived: sum of 2 quarters · filed 2026-03-02 | $1.38M derived: sum of 3 quarters · filed 2026-03-02 | $1.56M 10-K · filed 2026-03-02 |
| 2023-09-30 | $439.00K 10-Q · filed 2024-11-06 | $618.00K derived: sum of 2 quarters · filed 2024-11-06 | $796.00K 10-Q · filed 2024-11-06 | $975.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $179.00K 10-Q · filed 2024-08-07 | $357.00K 10-Q · filed 2024-08-07 | $536.00K derived: sum of 3 quarters · filed 2025-02-28 | $714.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $178.00K 10-Q · filed 2024-05-01 | $357.00K derived: sum of 2 quarters · filed 2025-02-28 | $535.00K derived: sum of 3 quarters · filed 2025-02-28 | $714.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $357.00K derived: sum of 2 quarters · filed 2025-02-28 | $536.00K derived: sum of 3 quarters · filed 2025-02-28 | $714.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $178.00K 10-Q · filed 2023-11-01 | $357.00K derived: sum of 2 quarters · filed 2023-11-01 | $535.00K 10-Q · filed 2023-11-01 | $714.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $179.00K 10-Q · filed 2023-08-02 | $357.00K 10-Q · filed 2023-08-02 | $536.00K derived: sum of 3 quarters · filed 2024-02-28 | $714.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $178.00K 10-Q · filed 2023-05-02 | $357.00K derived: sum of 2 quarters · filed 2024-02-28 | $535.00K derived: sum of 3 quarters · filed 2024-02-28 | $714.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $357.00K derived: sum of 2 quarters · filed 2024-02-28 | $536.00K derived: sum of 3 quarters · filed 2024-02-28 | $706.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $178.00K 10-Q · filed 2022-11-02 | $357.00K derived: sum of 2 quarters · filed 2022-11-02 | $527.00K 10-Q · filed 2022-11-02 | $692.00K derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $179.00K 10-Q · filed 2022-08-02 | $349.00K 10-Q · filed 2022-08-02 | $514.00K derived: sum of 3 quarters · filed 2022-08-02 | $680.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $170.00K 10-Q · filed 2022-05-04 | $335.00K derived: sum of 2 quarters · filed 2022-05-04 | $501.00K derived: sum of 3 quarters · filed 2022-05-04 | $666.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $165.00K 10-K · filed 2021-03-01 | $331.00K derived: sum of 2 quarters · filed 2021-11-03 | $496.00K derived: sum of 3 quarters · filed 2021-11-03 | $662.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $166.00K 10-Q · filed 2021-11-03 | $331.00K derived: sum of 2 quarters · filed 2021-11-03 | $497.00K 10-Q · filed 2021-11-03 | $697.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $165.00K 10-Q · filed 2021-08-04 | $331.00K 10-Q · filed 2021-08-04 | $531.00K derived: sum of 3 quarters · filed 2021-08-04 | $747.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $166.00K 10-Q · filed 2021-05-05 | $366.00K derived: sum of 2 quarters · filed 2021-05-05 | $582.00K derived: sum of 3 quarters · filed 2021-05-05 | $799.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $200.00K 10-K · filed 2021-03-01 | $416.00K derived: sum of 2 quarters · filed 2021-03-01 | $633.00K derived: sum of 3 quarters · filed 2021-03-01 | $849.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $216.00K 10-K · filed 2021-03-01 | $433.00K derived: sum of 2 quarters · filed 2021-03-01 | $649.00K 10-Q · filed 2020-11-05 | $865.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $217.00K 10-K · filed 2021-03-01 | $433.00K 10-Q · filed 2020-08-05 | $649.00K derived: sum of 3 quarters · filed 2021-03-01 | $865.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $216.00K 10-K · filed 2021-03-01 | $432.00K derived: sum of 2 quarters · filed 2021-03-01 | $648.00K derived: sum of 3 quarters · filed 2021-03-01 | $865.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $216.00K 10-K · filed 2020-02-26 | $432.00K derived: sum of 2 quarters · filed 2020-02-26 | $649.00K derived: sum of 3 quarters · filed 2020-02-26 | $865.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $216.00K 10-K · filed 2020-02-26 | $433.00K derived: sum of 2 quarters · filed 2020-02-26 | $649.00K 10-Q · filed 2019-11-07 | $865.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $217.00K 10-K · filed 2020-02-26 | $433.00K 10-Q · filed 2019-08-07 | $649.00K derived: sum of 3 quarters · filed 2020-02-26 | $1.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $216.00K 10-K · filed 2020-02-26 | $432.00K derived: sum of 2 quarters · filed 2020-02-26 | $1.21M derived: sum of 3 quarters · filed 2020-02-26 | $1.24M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $216.00K 10-K · filed 2019-02-28 | $996.00K derived: sum of 2 quarters · filed 2019-02-28 | $1.02M derived: sum of 3 quarters · filed 2019-02-28 | $1.05M 10-K · filed 2020-02-26 |
| 2017-09-30 | $780.00K 10-K · filed 2019-02-28 | $809.00K derived: sum of 2 quarters · filed 2019-02-28 | $837.00K 10-Q · filed 2018-10-31 | $866.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $29.00K 10-K · filed 2019-02-28 | $57.00K 10-Q · filed 2018-08-08 | $86.00K derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-03-31 | $28.00K 10-K · filed 2019-02-28 | $57.00K derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $29.00K 10-K · filed 2018-03-01 | $29.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |